Vaccine-induced Seropositivity in Participants of the APPROACH Study (HIV-V-A004)

被引：0
|
作者：
Lavreys, L. [1 ]
Callewaert, K. [1 ]
Vingerhoets, J. [1 ]
Colfer, A. [2 ]
Pau, M. G. [3 ]
Tomaka, F. [2 ]
机构：
[1] Janssen Pharmaceut NV, Beerse, Belgium
[2] Janssen Res & Dev, Raritan, NJ USA
[3] Janssen Vaccines & Prevent BV, Leiden, Netherlands
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2018年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P05.15LB
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [1] Vaccine-induced HIV seropositivity: A problem on the rise
    Van Braeckel, Eva
    Koutsoukos, Marguerite
    Bourguignon, Patricia
    Clement, Frederic
    McNally, Lisa
    Leroux-Roels, Geert
    JOURNAL OF CLINICAL VIROLOGY, 2011, 50 (04) : 334 - 337
  • [2] Vaccine-Induced HIV Seropositivity/Reactivity in Noninfected HIV Vaccine Recipients
    Cooper, Cristine J.
    Metch, Barbara
    Dragavon, Joan
    Coombs, Robert W.
    Baden, Lindsey R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (03): : 275 - 283
  • [3] Induction of Vaccine-Induced HIV Seropositivity in Preventative HIV Vaccine Trials
    Cooper, C. J.
    Wecker, M.
    Djomand, G.
    Metch, B.
    Dragavon, J.
    Coombs, R. W.
    Baden, L.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 103 - 103
  • [4] HIV vaccine-induced seropositivity common in clinical trials
    Reactions Weekly, 2010, 1312 (1) : 4 - 4
  • [5] New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
    O Penezina
    D Clapham
    J Collins
    V Kovalenko
    N Krueger
    IR Rodriguez-Chavez
    MP Busch
    AE Levin
    Retrovirology, 9
  • [6] New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
    Penezina, O.
    Clapham, D.
    Collins, J.
    Kovalenko, V.
    Krueger, N.
    Rodriguez-Chavez, I. R.
    Busch, M. P.
    Levin, A. E.
    RETROVIROLOGY, 2012, 9
  • [7] Performance of a Redesigned HIV Selectest Enzyme-Linked Immunosorbent Assay Optimized To Minimize Vaccine-Induced Seropositivity in HIV Vaccine Trial Participants
    Penezina, Oksana
    Krueger, Neil X.
    Rodriguez-Chavez, Isaac R.
    Busch, Michael P.
    Hural, John
    Kim, Jerome H.
    O'Connell, Robert J.
    Hunter, Eric
    Aboud, Said
    Higgins, Keith
    Kovalenko, Victor
    Clapham, David
    Crane, David
    Levin, Andrew E.
    CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (03) : 391 - 398
  • [8] "An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials
    Fatola, Omolayo
    Corneli, Amy
    Perry, Brian
    Hanlen-Rosado, Emily
    Nsonwu, Adora
    Constantine, Evangelia P.
    Thompson, Amelia B.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2022, 11 (05) : 221 - 224
  • [9] Exploring community understanding of HIV vaccine-induced seropositivity in Soshanguve, South Africa
    Malahleha, M.
    Malamatsho, R.
    Mbatsane, T. E.
    Keefer, M.
    Jean, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [10] Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials
    Durier, Christine
    Desaint, Corinne
    Lelievre, Jean-Daniel
    Silbermann, Benjamin
    Pialoux, Gilles
    Cuzin, Lise
    Bonnet, Benedicte
    Poizot-Martin, Isabelle
    Bouakane, Amel
    Paul, Christelle
    Grabar, Sophie
    Spire, Bruno
    Meyer, Laurence
    Launay, Odile
    Aboulker, Jean-Pierre
    Bertone, Helene
    Brezin, Antoine
    Clot, Lionel
    Diallo, Alpha
    Dore, Veronique
    Fleury, Herve
    Krivine, Anne
    Lewden, Charlotte
    Lidove, Olivier
    Linard, Francoise
    Meiffredy, Vincent
    Moulignier, Antoine
    Pastor-Jean, Marie-Josephe
    Pollard, Helene
    Rieux, Veronique
    Ross, Anna-Laura
    De Sauniere, Anne
    Viard, Jean-Paul
    AIDS, 2019, 33 (13) : 2061 - 2071
12345